IVZ vs. TPG: Which Stock Is the Better Value Option?

An analysis comparing Invesco (IVZ) and TPG Inc. (TPG) for value investors concludes that Invesco presents a superior value proposition. Invesco holds a Zacks Rank #2 (Buy) with an improving earnings outlook, while TPG is rated #3 (Hold). Key valuation metrics show IVZ with a significantly lower forward P/E of 12.15 compared to TPG's 28.82, a PEG ratio of 1.18 versus TPG's 1.48, and a P/B ratio of 0.65 against TPG's 6.16, resulting in a Value Grade of B for Invesco versus D for TPG.

Analysis

A comparative analysis of Invesco (IVZ) and TPG Inc. (TPG) in the investment management sector reveals a significant valuation disparity, positioning IVZ as a superior option for value-focused investors. This conclusion is supported by the Zacks Rank system, which rates IVZ as a #2 (Buy) due to positive earnings estimate revisions, while TPG is rated #3 (Hold). Quantitatively, IVZ trades at a substantial discount across key metrics, with a forward P/E ratio of 12.15 compared to TPG's 28.82. The price-to-earnings-growth (PEG) ratio further reinforces this, showing IVZ at a more favorable 1.18 versus TPG's 1.48. The most pronounced difference lies in the price-to-book (P/B) ratio, where IVZ's 0.65 indicates it is trading below its book value, a classic value signal, while TPG's P/B is a much higher 6.16. Consequently, IVZ earns a Value Grade of 'B' in contrast to TPG's 'D', solidifying its standing as the more attractive value proposition based on the provided framework.

Key Decisions for Investors

• Value-oriented investors should consider Invesco (IVZ) over TPG Inc. (TPG) due to its significantly more attractive valuation on P/E, PEG, and P/B metrics.
• The 'Buy' rating for IVZ is underpinned by an improving earnings outlook; investors should monitor for continued positive earnings estimate revisions to confirm the thesis.
• Given TPG's high valuation multiples and 'Hold' rating, investors should exercise caution and may want to await a more favorable entry point or a clear catalyst to justify its premium valuation relative to peers.